PATHWAY Anti-HER-2/neu (4B) Rabbit Monoclonal Primary Antibody

FDA Premarket Approval P990081 S048

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

DevicePATHWAY Anti-HER-2/neu (4B) Rabbit Monoclonal Primary Antibody
ApplicantVENTANA MEDICAL SYSTEMS, INC.1910 E. Innovation Park Dr.tucson, AZ 85755 PMA NumberP990081 Supplement NumberS048 Date Received07/12/2022 Decision Date07/29/2022 Advisory Committee Pathology Supplement Type30-day Notice Supplement Reason Process Change - Manufacturer/sterilizer/packager/supplier Expedited Review Granted? No
Date Received2022-07-12
Decision Date2022-07-29
PMAP990081
SupplementS048
Advisory CommitteePathology
Supplement Type30-day Notice
Supplement ReasonProcess Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination ProductNo
Applicant AddressVENTANA MEDICAL SYSTEMS, INC.
1910 E. Innovation Park Dr.
tucson, AZ 85755 PMA NumberP990081 Supplement NumberS048 Date Received07/12/2022 Decision Date07/29/2022 Advisory Committee Pathology Supplement Type30-day Notice Supplement Reason Process Change - Manufacturer/sterilizer/packager/supplier Expedited Review Granted? No Combination ProductNo Approval Order Statement  
addition Of Alternative Suppliers For Component Parts

Supplemental Filings

Supplement NumberDateSupplement Type
P990081Original Filing
S050 2022-10-14 30-day Notice
S049
S048 2022-07-12 30-day Notice
S047
S046 2022-02-16 Special (immediate Track)
S045 2022-01-28 135 Review Track For 30-day Notice
S044 2021-02-22 Real-time Process
S043 2020-08-26 Real-time Process
S042 2020-01-13 Real-time Process
S041 2019-08-22 Real-time Process
S040 2019-04-09 30-day Notice
S039 2019-02-13 Normal 180 Day Track
S038 2018-06-18 Real-time Process
S037
S036
S035 2016-11-15 Normal 180 Day Track
S034 2015-12-10 135 Review Track For 30-day Notice
S033 2015-08-26 30-day Notice
S032 2015-08-14 30-day Notice
S031 2014-10-27 30-day Notice
S030 2014-06-16 135 Review Track For 30-day Notice
S029 2014-02-14 Normal 180 Day Track
S028 2014-02-06 Real-time Process
S027 2014-01-22 Real-time Process
S026 2014-01-06 30-day Notice
S025 2013-12-27 30-day Notice
S024 2013-11-12 30-day Notice
S023 2013-10-28 30-day Notice
S022 2013-08-30 30-day Notice
S021 2013-07-30 30-day Notice
S020 2013-05-07 135 Review Track For 30-day Notice
S019 2013-05-06 Real-time Process
S018 2013-04-17 30-day Notice
S017 2013-03-12 Real-time Process
S016 2013-03-04 30-day Notice
S015 2013-01-14 Real-time Process
S014 2012-08-31 Real-time Process
S013 2012-07-27 30-day Notice
S012 2012-07-25 Real-time Process
S011 2011-05-23 Normal 180 Day Track
S010 2011-01-03 Normal 180 Day Track
S009
S008 2010-10-21 Special (immediate Track)
S007 2007-11-19 30-day Notice
S006 2007-06-27 30-day Notice
S005 2007-03-02 Special (immediate Track)
S004 2006-08-28 30-day Notice
S003 2006-05-04 Normal 180 Day Track
S002 2005-09-06 Real-time Process
S001 2002-08-20 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.